PYY3-36 inhibits the action potential firing activity of POMC neurons of arcuate nucleus through postsynaptic Y2 receptors

Cell Metabolism

Volumn 2, Issue 3, 2005, Pages 191-199

  Ghamari Langroudi, Masoud ^a   Colmers, William F ^b   Cone, Roger D ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

2 AMINO 5 PHOSPHONOVALERIC ACID; 6 NITRO 7 SULFAMOYLBENZO[F]QUINOXALINE 2,3 DIONE; L 152802; N [2 [1,2 DIHYDRO 3,5(4H) DIOXO 1,2 DIPHENYL 1,2,4 TRIAZOL 4 YL]ETHYL] N2 [[1 [2 [4 [5,11 DIHYDRO 6(6H) OXODIBENZ[B,E]AZEPIN 11 YL] 1 PIPERAZINYL] 2 OXOETHYL]CYCLOPENTYL]ACETYL]ARGININAMIDE; N2 DIPHENYLACETYL N (4 UREIDOMETHYLBENZYL)ARGININAMIDE; NALPHA (DIPHENYLACETYL) N (4 HYDROXYBENZYL) DEXTRO ARGININAMIDE; PEPTIDE YY; PICROTOXIN; POSTSYNAPTIC RECEPTOR; RECEPTOR BLOCKING AGENT; SODIUM CHANNEL BLOCKING AGENT; TETRODOTOXIN; UNCLASSIFIED DRUG; GREEN FLUORESCENT PROTEIN; NEUROPEPTIDE Y RECEPTOR; PROOPIOMELANOCORTIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARCUATE NUCLEUS; ARTICLE; BRAIN SLICE; COMPLEX FORMATION; CONTROLLED STUDY; DRUG RECEPTOR BINDING; MOUSE; NERVE CELL MEMBRANE POTENTIAL; NERVOUS SYSTEM ELECTROPHYSIOLOGY; NONHUMAN; POSTSYNAPTIC INHIBITION; PRIORITY JOURNAL; PROTEIN FUNCTION; REGULATORY MECHANISM; ACTION POTENTIAL; ANIMAL; COMPARATIVE STUDY; CYTOLOGY; DOSE RESPONSE; DRUG EFFECT; METABOLISM; NERVE CELL; PATCH CLAMP; PHYSIOLOGY; TIME; TRANSGENIC MOUSE;

ANIMALIA;

ACTION POTENTIALS; ANIMALS; ARCUATE NUCLEUS; DOSE-RESPONSE RELATIONSHIP, DRUG; GREEN FLUORESCENT PROTEINS; MICE; MICE, TRANSGENIC; NEURONS; PATCH-CLAMP TECHNIQUES; PEPTIDE YY; PRO-OPIOMELANOCORTIN; RECEPTORS, NEUROPEPTIDE Y; TIME FACTORS;

EID: 27744469753     PISSN: 15504131     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cmet.2005.08.003     Document Type: Article

References (37)

1. C.R. Abbott M. Monteiro C.J. Small A. Sajedi K.L. Smith J.R. Parkinson M.A. Ghatei S.R. Bloom The inhibitory effects of peripheral administration of peptide YY(3-36) and glucagon-like peptide-1 on food intake are attenuated by ablation of the vagal-brainstem-hypothalamic pathway Brain Res. 1044 2005 127-131
2. S.H. Adams W.B. Won S.E. Schonhoff A.B. Leiter J.R. Paterniti Jr. Effects of peptide YY[3-36] on short-term food intake in mice are not affected by prevailing plasma ghrelin levels Endocrinology 145 2004 4967-4975
3. T.E. Adrian G.L. Ferri A.J. Bacarese-Hamilton H.S. Fuessl J.M. Polak S.R. Bloom Human distribution and release of a putative new gut hormone, peptide YY Gastroenterology 89 1985 1070-1077
4. R.L. Batterham M.A. Cowley C.J. Small H. Herzog M.A. Cohen C.L. Dakin A.M. Wren A.E. Brynes M.J. Low M.A. Ghatei et. al. Gut hormone PYY(3-36) physiologically inhibits food intake Nature 418 2002 650-654
5. D. Bleakman W.F. Colmers A. Fournier R.J. Miller Neuropeptide Y inhibits Ca2+ influx into cultured dorsal root ganglion neurones of the rat via a Y2 receptor Br. J. Pharmacol. 103 1991 1781-1789
6. C. Broberger M. Landry H. Wong J.N. Walsh T. Hokfelt Subtypes Y1 and Y2 of the neuropeptide Y receptor are respectively expressed in pro-opiomelanocortin- and neuropeptide Y-containing neurons of the rat hypothalamic arcuate nucleus Neuroendocrinology 66 1997 393-408
7. C. Cabrele A.G. Beck-Sickinger Molecular characterization of the ligand-receptor interaction of the neuropeptide Y family J. Pept. Sci. 6 2000 97-122
8. B.G. Challis A.P. Coll G.S. Yeo S.B. Pinnock S.L. Dickson R.R. Thresher J. Dixon D. Zahn J.J. Rochford A. White et. al. Mice lacking pro-opiomelanocortin are sensitive to high-fat feeding but respond normally to the acute anorectic effects of peptide-YY(3-36) Proc. Natl. Acad. Sci. USA 101 2004 4695-4700
9. B.G. Challis S.B. Pinnock A.P. Coll R.N. Carter S.L. Dickson S. O'Rahilly Acute effects of PYY(3-36) on food intake and hypothalamic neuropeptide expression in the mouse Biochem. Biophys. Res. Commun. 311 2003 915-919
10. P.K. Chelikani A.C. Haver R.D. Reidelberger Intravenous infusion of peptide YY(3-36) potently inhibits food intake in rats Endocrinology 146 2005 879-888
11. M.A. Cowley J.L. Smart M. Rubinstein M.G. Cerdan S. Diano T.L. Horvath R.D. Cone M.J. Low Leptin activates anorexigenic POMC neurons through a neural network in the arcuate nucleus Nature 411 2001 480-484
12. J.E. Cox A. Randich Enhancement of feeding suppression by PYY(3-36) in rats with area postrema ablations Peptides 25 2004 985-989
13. H. Doods W. Gaida H.A. Wieland H. Dollinger G. Schnorrenberg F. Esser W. Engel W. Eberlein K. Rudolf BIIE0246: A selective and high affinity neuropeptide Y Y(2) receptor antagonist Eur. J. Pharmacol. 384 1999 R3-R5
14. Y. Dumont A. Fournier S. St.-Pierre R. Quirion Autoradiographic distribution of [125I]Leu31,Pro34]PYY and [125I]PYY3-36 binding sites in the rat brain evaluated with two newly developed Y1 and Y2 receptor radioligands Synapse 22 1996 139-158
15. B. El Bahh J.Q. Cao A.G. Beck-Sickinger W.E. Colmers Blockade of neuropeptide Y(2) receptors and suppression of NPY's anti-epileptic actions in the rat hippocampal slice by BIIE0246 Br. J. Pharmacol. 136 2002 502-509
16. S.O. Fetissov L.C. Byrne H. Hassani P. Ernfors T. Hokfelt Characterization of neuropeptide Y Y2 and Y5 receptor expression in the mouse hypothalamus J. Comp. Neurol. 470 2004 256-265
17. D. Grandt M. Schimiczek C. Beglinger P. Layer H. Goebell V.E. Eysselein J.R. Reeve Jr. Two molecular forms of peptide YY (PYY) are abundant in human blood: Characterization of a radioimmunoassay recognizing PYY 1-36 and PYY 3-36 Regul. Pept. 51 1994 151-159
18. M.M. Hagan Peptide YY: A key mediator of orexigenic behavior Peptides 23 2002 377-382
19. 3-36 produces conditioned taste aversion in mice Cell Metab. 1 2005 159-168
20. I.G. Halatchev K.L. Ellacott W. Fan R.D. Cone Peptide YY3-36 inhibits food intake in mice through a melanocortin-4 receptor-independent mechanism Endocrinology 145 2004 2585-2590
21. A. Kanatani A. Ishihara H. Iwaasa K. Nakamura O. Okamoto M. Hidaka J. Ito T. Fukuroda D.J. MacNeil L.H. Van der Ploeg et. al. L-152,804: orally active and selective neuropeptide Y Y5 receptor antagonist Biochem. Biophys. Res. Commun. 272 2000 169-173
22. D.A. Keire C.W. Bowers T.E. Solomon J.R. Reeve Jr. Structure and receptor binding of PYY analogs Peptides 23 2002 305-321
23. S. Koda Y. Date N. Murakami T. Shimbara T. Hanada K. Toshinai A. Niijima M. Furuya N. Inomata K. Osuye M. Nakazato The role of the vagal nerve in peripheral PYY3-36-induced feeding reduction in rats Endocrinology 146 2005 2369-2375
24. N.M. Martin C.J. Small A. Sajedi M. Patterson M.A. Ghatei S.R. Bloom Pre-obese and obese agouti mice are sensitive to the anorectic effects of peptide YY(3-36) but resistant to ghrelin Int. J. Obes. Relat. Metab. Disord. 28 2004 886-893
25. T.H. Moran U. Smedh K.P. Kinzig K.A. Scott S. Knipp E.E. Ladenheim Peptide YY(3-36) inhibits gastric emptying and produces acute reductions in food intake in rhesus monkeys Am. J. Physiol. Regul. Integr. Comp. Physiol. 288 2005 R384-R388
26. J.E. Morley A.S. Levine M. Grace J. Kneip Peptide YY (PYY), a potent orexigenic agent Brain Res. 341 1985 200-203
27. K. Obrietan A.N. van den Pol Neuropeptide Y depresses GABA-mediated calcium transients in developing suprachiasmatic nucleus neurons: A novel form of calcium long-term depression J. Neurosci. 16 1996 3521-3533
28. T.N. Pappas H.T. Debas Y. Goto I.L. Taylor Peptide YY inhibits meal-stimulated pancreatic and gastric secretion Am. J. Physiol. 248 1985 G118-G123
29. U. Pedersen-Bjergaard U. Host H. Kelbaek S. Schifter J.F. Rehfeld J. Faber N.J. Christensen Influence of meal composition on postprandial peripheral plasma concentrations of vasoactive peptides in man Scand. J. Clin. Lab. Invest. 56 1996 497-503
30. R.A. Pittner C.X. Moore S.P. Bhavsar B.R. Gedulin P.A. Smith C.M. Jodka D.G. Parkes J.R. Paterniti V.P. Srivastava A.A. Young Effects of PYY[3-36] in rodent models of diabetes and obesity Int. J. Obes. Relat. Metab. Disord. 28 2004 963-971
31. S.W. Robinson D.M. Dinulescu R.D. Cone Genetic models of obesity and energy balance in the mouse Annu. Rev. Genet. 34 2000 687-745
32. A.G. Roseberry H. Liu A.C. Jackson X. Cai J.M. Friedman Neuropeptide Y-mediated inhibition of proopiomelanocortin neurons in the arcuate nucleus shows enhanced desensitization in ob/ob mice Neuron 41 2004 711-722
33. K. Rudolf W. Eberlein W. Engel H.A. Wieland K.D. Willim M. Entzeroth W. Wienen A.G. Beck-Sickinger H.N. Doods The first highly potent and selective non-peptide neuropeptide Y Y1 receptor antagonist: BIBP3226 Eur. J. Pharmacol. 271 1994 R11-R13
34. S.P. Sheikh R. Hakanson T.W. Schwartz Y1 and Y2 receptors for neuropeptide Y FEBS Lett. 245 1989 209-214
35. K.A. Takahashi R.D. Cone Fasting induces a large, leptin-dependent increase in the intrinsic action potential frequency of orexigenic arcuate nucleus neuropeptide Y/Agouti-related protein neurons Endocrinology 146 2005 1043-1047
36. T. Talsania Y. Anini S. Siu D.J. Drucker P.L. Brubaker Peripheral Exendin-4 and Peptide YY3-36 Synergistically Reduce Food Intake through Different Mechanisms in Mice Endocrinology 146 2005 3748-3756
37. H.A. Wieland W. Engel W. Eberlein K. Rudolf H.N. Doods Subtype selectivity of the novel nonpeptide neuropeptide Y Y1 receptor antagonist BIBO 3304 and its effect on feeding in rodents Br. J. Pharmacol. 125 1998 549-555